ArticleChest2023

Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.

Sarah A R Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.